Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02024711 · ClinicalTrials.gov registry record · NA
EYEFILL® C. -US Viscoelastic Clinical Investigation
A NA study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- NA
- Development phase
- 262
- Enrollment target
NCT02024711: Completed NA study, sponsored by Bausch Health Americas.
NCT02024711 is a NA study that has completed, run by Bausch Health Americas. The registered enrollment target is 262 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02024711, a NA study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- NA
- Development phase
- 262 participants
- Enrollment target
Study Summary
The purpose of this multicenter, prospective, randomized clinical study is to determine the safety and effectiveness of the EYEFILL® C.-US Viscoelastic in patients undergoing cataract extraction and intraocular lens (IOL) implantation surgery. EYEFILL® C.-US Viscoelastic is designed to create and maintain space, to protect the corneal endothelium and other intraocular tissues, and to manipulate tissues during surgery. EYEFILL® C.-US Viscoelastic may also be used to coat intraocular lenses and instruments during cataract extraction and intraocular lens insertion.
Primary Outcome
Preservation of endothelium was assessed by specular microscope photographs to determine endothelial cell density.
Interventions
- DEVICE EYEFILL® C.-US Viscoelastic
- DEVICE Healon® Viscoelastic (CONTROL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-12-17 |
| Phase | NA |
What the finished NCT02024711 record still lists
NCT02024711 is an interventional study that assigns participants to a tested intervention. The registered 262 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which EYEFILL® C.-US Viscoelastic is the first listed.
NCT02024711 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02024711 about?
NCT02024711 is a clinical study titled "EYEFILL® C. -US Viscoelastic Clinical Investigation". The purpose of this multicenter, prospective, randomized clinical study is to determine the safety and effectiveness of the EYEFILL® C.-US Viscoelastic in patients undergoing cataract extraction and intraocular lens (IOL) implantation surgery. EYEFILL® C.-US Viscoelastic is designed to create and m...
What is the current status of trial NCT02024711?
This trial is currently completed. It is a NA study. The enrollment target is 262 participants. The study started on 2013-12. Estimated completion is 2014-12-17.
What interventions are being tested in trial NCT02024711?
The interventions under investigation include: EYEFILL® C.-US Viscoelastic (DEVICE), Healon® Viscoelastic (CONTROL) (DEVICE).
Who is sponsoring clinical trial NCT02024711?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02024711's enrollment target sits among peer trials
262 397th of 2000 higher than 1,604 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03713268 · 262 participants
Intraoperative OCT Guidance of Intraocular Surgery II
- NCT06074380 · 262 participants · Phase 4
Non Inferiority Trial Investigating Surfactants Administered Via MIST
- NCT06293703 · 262 participants · NA
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
- NCT06780137 · 262 participants · Phase 1
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia